Andrea Sacconi
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 125 publications
Chlorpromazine activates cGAS-STING signaling and reprograms the immune response in glioblastoma.
Journal: Frontiers in immunology
Published: November 10, 2025
Dissecting endometrial cancer complexity in response to standard and targeted therapies.
Journal: Cell death & disease
Published: July 09, 2025
p63 and ZNF148 cooperate to regulate head and neck squamous cell carcinoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 07, 2025
Nuclear gasdermin E drives endothelin-1-induced metastatic progression independently of the pyroptosis.
Journal: Cell death & disease
Published: June 27, 2025
DNA damaging agents boost the transcription of endothelin A receptor in high-grade serous ovarian cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 26, 2025
Development of an innovative duplex digital PCR assay for circulating MiRNA ratio quantification in metastatic melanoma.
Journal: Journal of translational medicine
Published: June 24, 2025
Proteomic profiling identifies a stromal TGF-β1/podoplanin axis as a driver of colorectal cancer progression.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 07, 2025
Androgen receptor inhibition sensitizes glioblastoma stem cells to temozolomide by the miR-1/miR-26a-1/miR-487b signature mediated WT1 and FOXA1 silencing.
Journal: Cell death discovery
Published: March 18, 2025
Correction: Valenti et al. The miR-205-5p/BRCA1/RAD17 Axis Promotes Genomic Instability in Head and Neck Squamous Cell Carcinomas. Cancers 2019, 11, 1347.
Journal: Cancers
Published: February 19, 2025
A predictive serum miRNA signature impacts diffuse large B-cell lymphoma cell viability via inhibition of EGLN1 and TXNRD1 regulators of ferroptosis.
Journal: British journal of haematology
Published: February 14, 2025
MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: February 06, 2025
Last Updated: 09/26/2026